176 related articles for article (PubMed ID: 11235597)
1. Post-prandial glycemic control: molecular targets for pharmacological intervention.
Chandalia HB
J Assoc Physicians India; 2001 Jan; 49 Spec No():11-6. PubMed ID: 11235597
[No Abstract] [Full Text] [Related]
2. [Pharmacological treatment of postprandial hyperglycemia].
Blickle JF
Diabetes Metab; 2000 Jun; 26 Suppl 2():20-4. PubMed ID: 10975046
[TBL] [Abstract][Full Text] [Related]
3. Improving post-prandial control with Humalog and Humalog mixtures.
Lüddeke HJ
Int J Clin Pract Suppl; 2000 Sep; (112):23-8. PubMed ID: 11064948
[No Abstract] [Full Text] [Related]
4. Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control.
Robertson C
Diabetes Educ; 2006; 32(3):423-32. PubMed ID: 16772658
[TBL] [Abstract][Full Text] [Related]
5. Treating hyperglycemia in type 2 diabetes: new goals and strategies.
Lebovitz HE
Cleve Clin J Med; 2002 Oct; 69(10):809-20. PubMed ID: 12371804
[TBL] [Abstract][Full Text] [Related]
6. Targeting prandial hyperglycemia: how important is it and how best to do this?
Monnier L; Colette C
Curr Diab Rep; 2008 Oct; 8(5):368-74. PubMed ID: 18778585
[TBL] [Abstract][Full Text] [Related]
7. Post-prandial hyperglycemia--the real challenge in diabetes.
Singh SK
J Assoc Physicians India; 2002 Nov; 50():1457; author reply 1457-8. PubMed ID: 12583492
[No Abstract] [Full Text] [Related]
8. [Postprandial hyperglycemia. II. Pharmacological approaches].
Scheen AJ; Letiexhe MR; Geronooz I; Paquot N; Jandrain B
Rev Med Liege; 2002 Apr; 57(4):196-201. PubMed ID: 12073790
[TBL] [Abstract][Full Text] [Related]
9. The role of blood glucose-lowering drugs in the light of the UKPDS. United Kingdom Prospective Diabetes Study.
Monnier L
Diabetes Obes Metab; 1999 Sep; 1 Suppl 2():S14-23. PubMed ID: 11221798
[No Abstract] [Full Text] [Related]
10. [Nateglinide and mitiglinide].
Odawara M
Nihon Rinsho; 2003 Jul; 61(7):1230-7. PubMed ID: 12877090
[TBL] [Abstract][Full Text] [Related]
11. Post-prandial hyperglycaemia--the necessity for better control.
Del Prato S
Int J Clin Pract Suppl; 2000 Sep; (112):3-8. PubMed ID: 11064944
[No Abstract] [Full Text] [Related]
12. [Effects of nateglinide in impaired glucose tolerance subjects].
Hirose T
Nihon Rinsho; 2005 Feb; 63 Suppl 2():438-43. PubMed ID: 15779419
[No Abstract] [Full Text] [Related]
13. [Significance of insulin secretion pattern lectured by "glinides" in the treatment of postprandial hyperglycemia].
Hirose T
Nihon Rinsho; 2005 Dec; 63(12):2237-44. PubMed ID: 16363700
[TBL] [Abstract][Full Text] [Related]
14. Using prandial insulin to achieve glycemic control in type 2 diabetes.
Dailey GE
J Fam Pract; 2007 Sep; 56(9):735-42. PubMed ID: 17764645
[No Abstract] [Full Text] [Related]
15. [The impact of regulation of postprandial glucose in practice].
Vergès B
Diabetes Metab; 1999 Dec; 25 Suppl 7():22-5. PubMed ID: 10746008
[TBL] [Abstract][Full Text] [Related]
16. Effect of different pharmacological formulations of gliclazide on postprandial hyperglycaemia.
Bardini G; Mannucci E; Rotella CM
Diabet Med; 1998 Aug; 15(8):706. PubMed ID: 9702477
[No Abstract] [Full Text] [Related]
17. [The current aspects of the pharmacological correction of hyperglycemia in patients with non-insulin-dependent diabetes mellitus (type 2)].
Gorbenko NI
Eksp Klin Farmakol; 1999; 62(5):71-8. PubMed ID: 10572759
[TBL] [Abstract][Full Text] [Related]
18. [Fast-acting insulin - new developments towards more flexibility for the patient].
Schmeisl GW; Kretzschmar Y
MMW Fortschr Med; 2016 Dec; 158(Suppl 6):5-11. PubMed ID: 27933575
[TBL] [Abstract][Full Text] [Related]
19. The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin.
Shaefer CF; Anderson J
Postgrad Med; 2016 Jan; 128(1):137-44. PubMed ID: 26548422
[TBL] [Abstract][Full Text] [Related]
20. Postprandial hyperglycemia: treating its atherogenic potential.
Geloneze B; Lamounier RN; Coelho OR
Arq Bras Cardiol; 2006 Nov; 87(5):660-70. PubMed ID: 17221045
[No Abstract] [Full Text] [Related]
[Next] [New Search]
